Corvus Pharmaceuticals In... (CRVS)

CRVS trades at $7.19, 43.8% above the near-term max pain of $5 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($4-$6), reflecting growing call interest at higher strikes. Key magnetic zone at 5 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for CRVS shows an upward trend from 4 to 6, suggesting bullish positioning in longer-dated options. The 40% spread signals divergent expectations across timeframes. Most levels below 7.19 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.